Methodologic shortcomings inherent in a post-hoc analysis.
Staskin
David R
DR
New York Presbyterian Hospital, Weill-Cornell Medical School, New York, NY 10021, USA. das2021@med.cornell.edu
D001559:Benzhydryl Compounds / Q000008:administration & dosage*; D018680:Cholinergic Antagonists / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D003408:Cresols / Q000008:administration & dosage*; D006801:Humans; D008333:Mandelic Acids / Q000008:administration & dosage*; D010665:Phenylpropanolamine; D013644:Tartrates / Q000008:administration & dosage*; D000068737:Tolterodine Tartrate; D001745:Urinary Bladder Diseases / Q000188:drug therapy*
D001559:Benzhydryl Compounds; D018680:Cholinergic Antagonists; D003408:Cresols; D008333:Mandelic Acids; D013644:Tartrates; D010665:Phenylpropanolamine; D000068737:Tolterodine Tartrate; C005419:oxybutynin